Abcentra LLC, a US-based clinical-stage biopharmaceutical company, has named Kevin B Bacon, PhD as its new chief executive officer, it was reported on Monday.

Bacon has over 30 years of pharmaceutical development experience. Prior to joining Abcentra LLC, Bacon was the president and chief executive officer of SMA Therapeutics Inc and acting CEO of Raft Pharmaceuticals, LLC. He was also the founder and CSO of Actimis Pharmaceuticals and former vice president of Respiratory Disease Therapeutic Area at Bayer.

Bacon received his PhD in Pharmacology from the University of London at the United Medical and Dental Schools of Guy's and St. Thomas' Hospitals.